BRK-B vs FRHC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FRHC exhibits a severe disconnect between its market price and fundamental value, highlighted by a Piotroski F-Score of 4/9 (Stable/Weak) and a Graham Number of $3.2 against a current price of $151.15. The company is currently trading at an astronomical P/E ratio of 7557.50, while reporting negative YoY revenue growth (-14.10%) and dismal profitability metrics (ROE of 0.22%). Despite a positive 5-year price trajectory, recent quarterly earnings have consistently missed estimates with an average surprise of -129.39%, suggesting a bubble-like valuation unsupported by current cash flow or earnings power.
Compare Another Pair
Related Comparisons
BRK-B vs FRHC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Freedom Holdings Corp. (FRHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.